Skip to main content
NeuronFeed
Home Investors Andreessen Horowitz (Bio + Health)

Andreessen Horowitz (Bio + Health)

Active VC
Portfolio Active
2
Latest Genesis Molecular AI
Deal flow
$400M
2 rounds
Unicorns
0
≥ $1B valuation
Founded
—
Latest
Aug 2023
Genesis Molecular AI

About Andreessen Horowitz (Bio + Health)

Venture capital firm tracking 2 AI investments, with focus on Drug Discovery and US startups. Total tracked deal flow: $400M.

Sector focus

💊 Drug Discovery 2
🏥 AI Healthcare 1

Geographic focus

US 1

Portfolio

2

Genesis Molecular AI

Generative AI for small-molecule drug discovery

Genesis Therapeutics

Co-investors

8

Fidelity Management & Research

2 shared

BlackRock

2 shared

Rock Springs Capital

1 shared

NVentures (NVIDIA)

1 shared

NVentures

1 shared

Radical Ventures

1 shared

Menlo Ventures

1 shared

Andreessen Horowitz

1 shared

Recent rounds

2
Aug 29, 2023 Series B $200M Genesis Molecular AI
Series B $200M Genesis Therapeutics